Furoscix is expected to be available for CKD patients in April 2025. The Food and Drug Administration (FDA) has expanded the approval of Furoscix ® (furosemide injection) to include the treatment ...

Early and accurate prognostic evaluation in these patients is vital for guiding clinical management. Our aim was to explore the association between albumin-corrected calcium (ACC) and mortality in ...

Learn about the increased pressure in the portal vein, its causes like cirrhosis, and resulting complications such as ...

Objectives In severe heart disease, parenteral administration of loop diuretic is often needed. We present clinical outcomes from episodes of care using subcutaneous continuous subcutaneous infusion ...

The following is a summary of "Eplerenone, diabetes, and chronic kidney disease in patients hospitalized for acute heart ...

However, they were found to have poor diagnostic accuracy in the presence of abnormal albumin concentrations, FDH, NTI, high FFA levels or with thyroid hormone autoantibodies. Considerable efforts ...

BMS-986458 features three stereocenters, one of which epimerizes easily, Mortensen said. The drug candidate, which would be ...

[9,10] The main loop diuretics used in the United States are furosemide, bu-metanide, and torsemide. Thiazide diuretics, such as metolazone, are less potent than loop diuretics and are therefore ...

Dr. David M. Dudzinski: A 72-year-old woman was evaluated at this hospital because of altered mental status. Five years before the current admission, the patient underwent transurethral resection ...

NDA submission based on results from Phase 3 DUPLEX and Phase 2 DUET studies of FILSPARI in FSGSIf approved, FILSPARI could become the first and ...